Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Leqvio — US MOTRx Growth (% YoY) by Quarter
Leqvio — US MOTRx Growth (% YoY) (%)
Novartis Leqvio — US MOTRx Growth (% YoY): 60.0% in Q3 2026, up 16.0 pts from a year earlier.
Where the Q3 2026 figure comes from
“Appendix | USD m, % cc | • MOTRx growth (+60%) ahead of market (+46%) and main competitor (+46%), reflecting Leqvio’s”
Source: Novartis Official IR / Sustainability Report — q3-2026-investor-presentation.pdf ↗
Reported in Quarterly Investor Presentations.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Leqvio — US MOTRx Growth (% YoY) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 60.0% | +16.0 pts | Novartis Official IR / Sustainability Report — q3-2026-investor-presentation.pdf ↗ |
| Q2 2026 | Jun 30, 2026 | 49.0% | -7.0 pts | Novartis Official IR / Sustainability Report — q2-2026-investor-presentation.pdf ↗ |
| Q1 2026 | Mar 31, 2026 | 41.0% | -29.0 pts | Novartis Official IR / Sustainability Report — q1-2026-investor-presentation.pdf ↗ |
| Q4 2025 | Dec 31, 2025 | 56.0% | – | Novartis Official IR / Sustainability Report — q4-2025-investor-presentation.pdf ↗ |
| Q3 2025 | Sep 30, 2025 | 44.0% | – | Novartis Official IR / Sustainability Report — q3-2025-investor-presentation.pdf ↗ |
| Q2 2025 | Jun 30, 2025 | 56.0% | – | Novartis Official IR / Sustainability Report — q2-2025-investor-presentation.pdf ↗ |
| Q1 2025 | Mar 31, 2025 | 70.0% | – | Novartis Official IR / Sustainability Report — q1-2025-investor-presentation.pdf ↗ |
Breakdown
What makes up leqvio — US MOTRx Growth (% YoY)
Cite this data
StockData. (2026). Novartis Leqvio — US MOTRx Growth (% YoY) (%), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rx-leqvio-us-motrx-yoy-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.